Oscar Health Q2 Earnings Call Highlights
Oscar Health (OSCR) reported Q2 SG&A ratio at a record low 14.2%, down 450 bps YoY, citing expense discipline and AI initiatives. It received a final 2025 CMS risk-adjustment report about $160M favorable, fully recognized in Q2, and initial 2026 report based on four months of claims. Management expects higher churn in H2 and stable MLR seasonally.
How this was made
The 30-second read
Why it matters
Traders can update near-term underwriting and expense models using the stated SG&A seasonality (stable in Q3, higher in Q4), the timing of CMS risk-adjustment recognition, and the expectation that MLR rises seasonally in the second half.
Market read
Management’s Q3 SG&A stability call, CMS risk-adjustment timing, and updated churn outlook can influence short-horizon estimate revisions and positioning ahead of subsequent quarterly prints.
What to watch
The outpatient trend is described as stable but elevated, and churn is expected to nearly double versus prior estimates, even if management frames it as timing rather than full-year revenue impact.
Background
The piece summarizes Oscar Health’s Q2 earnings call, focusing on SG&A ratio, CMS risk-adjustment updates, utilization/MLR seasonality, AI initiatives, and updated churn expectations.
Ticker impact
Oscar said its SG&A expense ratio hit a record low 14.2% and guided it to stay stable in Q3 before rising in Q4.
Moderate upside bias if investors focus on record-low SG&A and favorable risk-adjustment recognition, but churn and outpatient utilization could temper the reaction.
The article includes specific management guidance on SG&A seasonality, risk-adjustment recognition timing, and MLR/utilization expectations, which are actionable for near-term estimates even without full financial figures.
Market effects
Highlights how ACA insurers may use AI-driven claims processing and radiology site-of-care tools to reduce variable costs and improve medical economics.
Primarily US ACA individual market sentiment, with potential read-through to managed-care peers’ underwriting assumptions.
Limited, as the disclosures are US Medicare/ACA program-specific (CMS risk adjustment, churn, MLR seasonality).
Counterpoint
The favorable risk-adjustment and SG&A improvements may be partially offset by outpatient utilization elevation and higher churn timing, which could pressure revenue quality and medical cost trends later in the year.
Key entities
- companyOscar Health
US ACA-focused health insurer discussing Q2 cost, CMS risk-adjustment, utilization, AI initiatives, and churn guidance.
- regulatory_programCMS risk-adjustment
Federal risk-adjustment reports that affect accruals and recognized favorable amounts for Oscar.
- technologyOswell agent
AI tool piloted for radiology site-of-care recommendations, with reported savings and adoption rate.
- product_platformICHRAx platform
Oscar’s platform supporting ICHRA employer arrangements, built on an acquired electronic data exchange.
